Delivery Order SPE2DB25D3404-SPE2DB25FUNCS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of XEOMIN 200 unit vials, with a ceiling value of $2,234.96 and an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive set-aside and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for 100-unit vials of XEOMIN on August 21, 2025. The contract has a ceiling value of $2,514.33 and represents a firm fixed-price delivery order with a completion date of September 12, 2025. This award carries no set-aside designation and was competitively awarded through DLA's procurement process. The place of performance is located...
- The Defense Logistics Agency awarded a delivery order valued at $4,190.55 to AmerisourceBergen Drug Corp for the procurement of XEOMIN 100 Unit Vials, with an ultimate completion date of July 10, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, with a ceiling value of $1,955.59 for the supply of XEOMIN 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for XEOMIN 100 Unit vials with a ceiling value of $8,381.10. This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $27,937.00 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with a completion date of July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,263.62 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued on July 23, 2025, was competitively awarded without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of XEOMIN 100 UT vials valued at $11,174.80. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded through open competition without set-aside provisions. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of XEOMIN 100 Unit vials. This firm fixed-price delivery order, valued at $23,467.08, represents a non-competitive set-aside award and is scheduled for completion by August 7, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award is issued as a child order under...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUNCSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,174.80 to supply 200-unit vials of XEOMIN on April 24, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a comprehensive $999.99 billion vehicle running through December 2026 that authorizes the distributor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts serving defense and veteran healthcare systems through the DLA Medical Supply Chain. The company's track record demonstrates capability in fulfilling diverse pharmaceutical requirements ranging from specialty medications and brand-name drugs to vaccines and medical devices across multiple therapeutic domains. This XEOMIN delivery order exemplifies the company's role as a critical vendor supporting the Defense Health Agency and broader federal healthcare procurement needs through its flexible contracting vehicles and competitive positioning in the pharmaceutical distribution market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 4/24/25 |